238 related articles for article (PubMed ID: 32832571)
1. Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy.
Wang Z; Zhang L; Wang J; Wang Y; Dong Q; Piao H; Wang Q; Zhang J
J Immunol Res; 2020; 2020():6813176. PubMed ID: 32832571
[TBL] [Abstract][Full Text] [Related]
2. Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer.
Zhang L; Zhang J; Wang Y; Dong Q; Piao H; Wang Q; Zhou Y; Ding Y
J Clin Lab Anal; 2019 Oct; 33(8):e22958. PubMed ID: 31218745
[TBL] [Abstract][Full Text] [Related]
3. Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab.
Lee CK; Kim SS; Park S; Kim C; Heo SJ; Lim JS; Kim H; Kim HS; Rha SY; Chung HC; Park S; Jung M
Oncotarget; 2017 May; 8(19):31169-31179. PubMed ID: 28415714
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
5. Sodium to globulin ratio as a prognostic factor for patients with advanced gastric cancer.
Zhang L; Wang Z; Xiao J; Chen H; Zhang Z; Li H; Wang Y; Piao H; Li F; Zhang L; Zhang J
J Cancer; 2020; 11(24):7320-7328. PubMed ID: 33193896
[No Abstract] [Full Text] [Related]
6. Predicting the Prognosis of Gastric Cancer by Albumin/Globulin Ratio and the Prognostic Nutritional Index.
Zhang Y; Zhu JY; Zhou LN; Tang M; Chen MB; Tao M
Nutr Cancer; 2020; 72(4):635-644. PubMed ID: 31423840
[No Abstract] [Full Text] [Related]
7. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
Tong Y; Zhao Y; Shan Z; Zhang J
BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
9. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
Ji H; Liu B; Jin P; Li Y; Cui L; Jin S; Wu J; Shan Y; Zhang Z; Ming J; Zhang L; Du C
Front Immunol; 2024; 15():1364728. PubMed ID: 38665913
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Seo S; Park SJ; Ryu MH; Park SR; Ryoo BY; Park YS; Na YS; Lee CW; Lee JK; Kang YK
Oncotarget; 2017 May; 8(20):33844-33854. PubMed ID: 27802183
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy.
Zhang L; Wang Z; Xiao J; Zhang Z; Li H; Wang Y; Dong Q; Piao H; Wang Q; Bi F; Li F; Zhang J
Oncol Lett; 2020 Oct; 20(4):10. PubMed ID: 32774483
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
[TBL] [Abstract][Full Text] [Related]
13. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer.
Bi Y; Zhang J; Zeng D; Chen L; Ye W; Yang Q; Ling Y
Pathol Oncol Res; 2021; 27():580800. PubMed ID: 34257526
[No Abstract] [Full Text] [Related]
15. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.
Li QQ; Lu ZH; Yang L; Lu M; Zhang XT; Li J; Zhou J; Wang XC; Gong JF; Gao J; Li J; Li Y; Shen L
Asian Pac J Cancer Prev; 2014; 15(2):945-50. PubMed ID: 24568523
[TBL] [Abstract][Full Text] [Related]
16. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
Guo X; Zhao F; Ma X; Shen G; Ren D; Zheng F; Du F; Wang Z; Ahmad R; Yuan X; Zhao J; Zhao J
BMC Cancer; 2019 Nov; 19(1):1125. PubMed ID: 31747911
[TBL] [Abstract][Full Text] [Related]
17. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
18. Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.
Namikawa T; Munekage E; Munekage M; Maeda H; Yatabe T; Kitagawa H; Kobayashi M; Hanazaki K
Oncology; 2016; 90(6):321-6. PubMed ID: 27225990
[TBL] [Abstract][Full Text] [Related]
19. Association between common genetic variants in pre-microRNAs and prognosis of advanced gastric cancer treated with chemotherapy.
Tahara T; Okubo M; Shibata T; Kawamura T; Sumi K; Ishizuka T; Nagasaka M; Nakagawa Y; Arisawa T; Ohmiya N; Hirata I
Anticancer Res; 2014 Sep; 34(9):5199-204. PubMed ID: 25202115
[TBL] [Abstract][Full Text] [Related]
20. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]